SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- cardiovascular
An SI Board Since May 2001
Posts SubjectMarks Bans
214 28 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
89diaDexus Study Shows Lp-PLA2 to Be an Independent Risk Marker for Coronary Arternigel bates-8/31/2004
88(ENCY / sitaxsentan) Data on Thelin(TM) Presented at the European Society of Carnigel bates-8/31/2004
87Study endorses Glaxo's (Lp-PLA2) new heart drug approach Tuesday August 31, nigel bates-8/31/2004
86NitroMed Stops Heart Failure Study -A-HeFT- in African Americans Due to Significnigel bates-7/19/2004
85[Vasorin is a potential therapeutic target for vascular fibroproliferative disortuck-7/12/2004
84[Inhibition of GSK-3B is cardioprotective] jci.org Cheers, Tucktuck-6/6/2004
83Nature. 2004 May 13;429(6988):188-93. Citric acid cycle intermediates as ligascaram(o)uche-5/15/2004
82Agriculture and the Paleolithic Diet [Some thoughts on the merits of Phase 2 PrIcebrg-4/21/2004
81[Cancer fighting broccoli also good for cardiovascular problems?] >>Publituck-4/21/2004
80Vernalis V10153 (thrombin-activatable plasminogen) - Phase IIa study completed nigel bates-3/30/2004
79from Aderis/King.......... Circulation. 2004 Jan 20 [Epub ahead of print] Ranscaram(o)uche-1/23/2004
78New Study Shows EECP Therapy as a Potential First Line Treatment for Patients Sunigel bates-1/9/2004
77NicOx 4016 / PAOD PIIA results NCX 4016 Successfully Achieves Primary Efficacy nigel bates-1/8/2004
76thanks for finding that! (eom)scaram(o)uche-12/12/2003
75New Clue to Sudden Coronary Death Tiny hemorrhage can cause plaque rupture By JMarcus-12/12/2003
74just parking for nomenclature and perspective. SLV320 from Solvay is not mentioscaram(o)uche-12/12/2003
73Actelion and Merck Form Renin Inhibitor Alliance ALLSCHWIL/BASEL, Switzerland anigel bates-12/4/2003
72First some background,...for the wino's (gggggg) <i>Polyphenols are arusset-11/18/2003
71[Therapeutic Angiogenesis for Cardiovascular Disease] Pretty thorough overview tuck-11/18/2003
70Tuck, It appears that Enox is more effective than Dobutamine (at least as i.v. Miljenko Zuanic-11/17/2003
69>>Enoximone, a type-III selective phosphodiesterase inhibitor, is a positituck-11/17/2003
68deCODE Licenses (Bayer) Developmental Compound, Expects to Start Enrollment for nigel bates-11/17/2003
67Albumin Reduces Mortality in Coronary Artery Bypass Graft (CABG) Surgery <i&nigel bates-10/30/2003
66Actelion / renin inhibitor / (request for partner...) <i>LONDON, Oct 29 (nigel bates-10/29/2003
65Interesting results. Maybe it is worth further investigation.Miljenko Zuanic-10/16/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News